Document Detail

Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing their first treatment cycle of IVF or ICSI.
MedLine Citation:
PMID:  20602599     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To test whether the clinical efficiency of recombinant FSH (rFSH) and highly purified human menotrophin (hMG) differs in terms of pregnancy and live birth rates during the first treatment cycle of IVF or ICSI. DESIGN: Prospective cohort study. SETTING: Department of Gynecology and Obstetrics, Rikshospitalet, Oslo University Hospital. STUDY POPULATION: Records of 1,136 infertile couples undergoing their first IVF (n = 682) or ICSI (n = 454) treatments were reviewed. The effect of hMG and rFSH was analyzed for the IVF and ICSI groups separately. METHODS: Patients received long term down-regulation with GnRH agonist and controlled ovarian hyperstimulation with hMG or rFSH. Oocytes were fertilized by IVF or ICSI. Embryos were transferred on Day 2. MAIN OUTCOME MEASURES: Primary outcome measures were pregnancy and live birth rates, secondary outcome measures were duration of treatment, doses of hMG or rFSH applied, number of oocytes retrieved and the number and quality of embryos obtained. RESULTS: Similar pregnancy and live birth rates were observed with hMG and rFSH. Compared to hMG, treatment cycles with rFSH were characterized by significantly shorter stimulation, lower gonadotrophin consumption, and increased number of oocytes and embryos. CONCLUSION: We conclude that rFSH and hMG are equivalent in terms of clinical efficacy.
Sverre Bjercke; Tom Tanbo; Thomas Abyholm; Anne Omland; Hans Kristian Opøien; Peter Fedorcsak
Related Documents :
1500479 - Fallopian tube sperm perfusion used in a donor insemination programme.
3656299 - Planned parenthood experience with triphasil.
20548909 - The influence of pregnancy and menstruation on the deterioration of atopic dermatitis s...
1426389 - Intrauterine insemination after ovarian stimulation as a treatment for subfertility bec...
8195349 - Regulation of corpus luteum function.
14664409 - Effect of short follicular phase with follicular maturity on conception outcome.
10233849 - Human trophoblast invasion and spiral artery transformation: the role of nitric oxide.
3426989 - Energy intake and physical activity during pregnancy in relation to maternal fat accret...
10719409 - Nutrition and multifetal pregnancy.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Acta obstetricia et gynecologica Scandinavica     Volume:  89     ISSN:  1600-0412     ISO Abbreviation:  Acta Obstet Gynecol Scand     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-07-19     Completed Date:  2010-08-12     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370343     Medline TA:  Acta Obstet Gynecol Scand     Country:  England    
Other Details:
Languages:  eng     Pagination:  1053-60     Citation Subset:  IM    
Department of Obstetrics and Gynecology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Buserelin / therapeutic use
Embryo, Mammalian
Fertility Agents, Female / therapeutic use*
Fertilization in Vitro
Follicle Stimulating Hormone / therapeutic use*
Hormones / therapeutic use*
Live Birth*
Menotropins / therapeutic use*
Ovulation Induction / methods*
Pregnancy Rate*
Prospective Studies
Sperm Injections, Intracytoplasmic
Time Factors
Reg. No./Substance:
0/Fertility Agents, Female; 0/Hormones; 57982-77-1/Buserelin; 61489-71-2/Menotropins; 9002-68-0/Follicle Stimulating Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Abstracts.
Next Document:  Early postpartum hysterectomy: incidence and risk factors.